March 26, 2025 - 23:45
Shares of Marvell Technology experienced a significant decline, dropping 7.9% during the afternoon trading session. This downturn occurred as broader market indices also faced setbacks, with the Nasdaq falling by 1.5% and the S&P 500 declining by 1.2%. The market's instability was largely attributed to renewed apprehensions regarding trade tariffs, following recent statements from President Trump.
In his remarks, Trump elaborated on the administration's 25% tariffs, specifically addressing the implications for countries engaging in trade with Venezuela. This announcement raised alarms among investors, particularly regarding the impact on existing tariffs, such as the additional 25% imposed on top of the already established 20% tariff on China, a major player in the global oil market.
As the trade landscape continues to evolve, companies like Marvell Technology may face increased volatility, prompting investors to reassess their positions in light of potential economic repercussions stemming from these trade policies.
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...